BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Innovate Biopharmaceuticals’ Dose Response Data for Larazotide Acetate Demonstrating Its Unique Mechanism of Action and Applications in Diseases Caused by Increased Intestinal Permeability

  The data reveal a narrow dose response for larazotide with the higher doses showing inhibition.

  December 28, 2017

   · 

  3 min read
• Business

  Integrity Applications Signs Distribution Agreement for its GlucoTrack Non-Invasive Glucose Monitoring Device in the Netherlands

  The agreement became effective on December 22nd, 2017.

  December 28, 2017

   · 

  5 min read
• Business

  PetVivo Hires Randy Wenthold to Replace David Masters as Chief Technical Officer

  Mr. Wenthold has been involved with medical devices from a development, manufacturing, and division management role for over 25 years.

  December 28, 2017

   · 

  3 min read
• Pharm Country

  Cancer Genetics Receives Non-Dilutive Funding of $1.1M Through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

  The payment, received in December 2017, is net of administrative and sales expenses and fees associated with the program.

  December 28, 2017

   · 

  3 min read
• Deals

  Endonovo Therapeutics Provides Update on Acquisition of PEMF Assets, Clinical Pipeline and Pre-Clinical Study

  The Company is currently in the process of transferring all of the assets it has acquired from Rio Grande Neurosciences and registering with the FDA to become regulatory compliant.

  December 28, 2017

   · 

  6 min read
• Deals

  Digirad Announces Sale of Its MDSS Service Contracts to Philips North America

  Total consideration under the Agreement is $8 million.

  December 28, 2017

   · 

  2 min read
• Genetown

  Acer Therapeutics Announces Partial Exercise of Over-Allotment Option in Public Offering

  Acer intends to use the net proceeds from this offering to fund its research and development efforts, to seek regulatory approval for EDSIVO.

  December 28, 2017

   · 

  4 min read
• Policy

  TherapeuticsMD Announces Submission of New Drug Application for TX-001HR

  The NDA submission is supported by the complete TX-001HR clinical program, including positive results of the recently completed phase 3 Replenish Trial.

  December 28, 2017

   · 

  4 min read
• Emerald Health Therapeutics Awards Stock Options

  The Options have been granted pursuant to the Company’s Omnibus Incentive Plan which has been previously approved by the Company’s shareholders and the TSX Venture Exchange.

  December 28, 2017

   · 

  2 min read
• Business

  MDxHealth Announces Lowering of 2017 Guidance

  The next update will be provided on February 22, 2018 together with the full year financial results for 2017.

  December 28, 2017

   · 

  5 min read